The Rian Johnson mystery franchise is coming back with a slew of A-list stars. By Lexy Perez Associate Editor Daniel Craig’s Benoit Blanc is ready to solve another mystery. Craig will reprise ...

Feb 5 (Reuters) - Johnson Controls International (JCI.N), opens new tab named Joakim Weidemanis as chief executive officer and lifted its 2025 profit forecast on Wednesday, sending its shares up ...

Bryan Johnson has dropped the medicine he had been taking for last five years. Bryan Johnson, the 47-year-old tech entrepreneur who has spent millions on his quest to reverse his biological age ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

Less than 48 hours after their season came to an end, the Lions lost again. On Monday, Ben Johnson decided to leave his post as Detroit's offensive coordinator. He will reportedly stay in the NFC ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...

The Bears are finalizing a deal, sources told the Tribune on Monday, to hire Detroit Lions offensive coordinator Ben Johnson, who was hotly pursued by the Las Vegas Raiders and Jacksonville Jaguars.

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.

Rep. Thomas Massie, one of the most outspoken critics of House Speaker Mike Johnson, is off the powerful House Rules Committee, which plays a critical role in the functioning of the lower chamber ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Now, as they head into two years of total Republican control over the federal government’s levers of power, the alliance between Johnson and Trump may prove to be one of the most important ...